Descargar - Úlceras.net

46 ■ PIE DIABÉTICOBIBLIOGRAFÍA1. Marinel-lo J, Blanes JI, Escudero JR, et al. Consenso de laSEACV sobre pie diabético. Angiología 1997; 5: 193-230.2. Fryberg RG, Armstrong DG, Giurini J et al. Diabetic footdisorders: A clinical practice guideline. J Foot Ankle Surg2000; 39: S1-S60.3. Lipsky BA. Medical treatment of diabetic foot infections.Clin Infect Dis 39 (Suppl 2): S104-S114, 2004.4. Lipsky BA, Berendt AR, Embil J, De Lalla F. Diagnosing andTreating diabetic foot infections. Diabetes Metb Res Rev2004; 20: S56-64.5. Bowler PG, Duerden BI, Armstrong DG. Wound microbiologyand associated approaches to wound Management.Clin Microbiol Rev 2001; 14: 244-69.6. Karchmer AW, Gibbons GW. Foot infections in diabetes:evaluations and Management. Curr Clin Top Infect Dis1994; 14: 1-22.7. Gerding DN. Foot infections in diabetic patients: the role ofanaerobes. Clin Infect Dis 1995; 20: S283-8.8. Diamantopoulos EJ, Haritos D, Yfandi G, et al. Managementand outcome of severe diabetic foot infections. Exp ClinEndocrinol Diabetes 1998; 106: 346-52.9. Dow G, Browne A, Sibbald RG. Infection in chronic wounds:controversies in diagnosis and treatment. Ostomy WoundManage 1999; 45: 23–40.10. Senior C. Assessment of infection in diabetic foot ulcers. JWound Care 2000; 9: 313–7.11. Robson MC, Mannari RJ, Smith PD, Payne WG. Maintenanceof wound bacterial balance. Am J Surg 1999; 178: 399–402.12. Boyko EJ, Lipsky BA. Infection and diabetes. In Diabetes inAmerica, 2nd edition, NIH Publication No 95-1468. 1995:485–499.13. Shah B, Hux J. Quantifying the risk of infectious diseases forpeople with dia- Bet es. Diabetes Care 2003; 26: 510–3.14. Mayfield JA, Reiber GE, Sanders LJ, Janisse D, Pogach LM.Preventive foot care in people with diabetes. DiabetesCare 1998;21:2161–77.15. Boulton AJM, Vileikyte L, Ragnarson-Tennvall G, Apelqvist J.The global burden of diabetic foot disease. Lancet 2005;336: 1719–24.16. Lipsky BA. Infectious problems in diabetic patients. In: Levinand O’Neal’s The Diabetic Foot (6th ed). Bowker JH,Pfeifer MA, eds. St Louis: Mosby. 2001: 467–80.17. Sato N, Shimizu H, Suwa K, Shimomura Y, Kobayashi I, MoriM. MPO activity and generation of active O2 species in leukocytesfrom poorly controlled diabetic patients. DiabetesCare 1992; 15: 1050–2. classification in relation to the finaloutcome. Wounds 2002; 14: 16–25.18. Marhoffer W, Stein M, Maeser E, Federlin K. Impairment ofpolymorphonu- clear leukocyte function and metaboliccontrol of diabetes. Diabetes Care 1992; 15: 256–60.19. Gallacher SJ, Thomson G, Fraser DW, Fisher BM, GemmellCG, MacCuish AC. Neutrophil bactericidal function in diabetesmellitus: evidence for association with blood glucosecontrol. Diabet Med 1995; 12: 916–20.20. Alexiewicz JM, Kumar D, Smogorzewski H, Klin M, MassryMG. Polymor- phonuclear leucocytes in non-insulin-dependentdiabetes mellitus: abnorma- lities in metabolism andfunction. Ann Intern Med 199 5; 123: 919–24. Clin InfectDis 2004; 39: S83–6.21. Delamaire M, Maugendre D, Moreno M, Le Goff MC, AllanicH, Genetet B. Impaired leucocyte functions in diabeticpatients. Diabet Med 1997; 14: 29–34.tes: a controlled trial.Diabet Med 1996; 13: 156–9.22. Muchová J, Liptáková A, Országhová Z, et al. Antioxydantsystem in poly- morphonuclear leucocytes of type 2 diabetesmellitus. Diabet Med 1999; 16: 74–8.23. Rai NK, Suryabhan, Ansari M, Kumar M, Shukla VK, TripathiK. Effect of glycaemic control on apoptosis in diabeticwounds. J Wound Care 2005; 14: 277–81.24. Vigilance JE, Reid HL. Glycaemic control influences peripheralblood flow and haemorheological variables in patientswith diabetes mellitus. Clin He- morheol Microcirc 2005;33: 337–46.25. Conférence de consensus. Érysipèle et fasciite nécrosante.Med Mal Infect 2000; 30: 241–5.26. International Working Group on the Diabetic Foot.International consensus on the diabetic foot (CD-ROM).2003. In: International Diabetes Foundation; Brussels.http://www.iwgdf.org.27. Edmonds M. Infection in the neuroischemic foot. Int J LowExtrem Wounds 2005; 4: 145–53.28. Berendt T, Lipsky BA. Is bone infected or not?Differentiating neuro-os- teoarthropathy from osteomyelitisin the diabetic foot. Curr Diab Rep 2004; 4: 424–9.29. Eneroth M, Apelqvist J, Stenstrom A. Clinical characteristicsand out- come in 223 diabetic patients with deep footinfections. Foot Ankle Int 1997; 18: 716–22.30. Eneroth M, Larsson J, Apelqvist J. Deep foot infections inpatients with diabetes and foot ulcer: an entity with differentcharacteristics, treatments, and prognosis. J DiabetesComplications 1999; 13: 254–63.31. Cavanagh PR, Lipsky BA, Bradbury AW, Batek G. Treatmentfor diabetic foot ulcers. Lancet 2005; 366: 1725–35.32. Bernard, l , Lavigne, JP et al. Recommandations pour la practiqueChinique. Prise en charge du pied diabétique infecté.Medicine et maledies infectieuses. 2007; 37: 26-50.33. Armstrong DG, Lavery LA, Sariaya M, Ashry H. Leukocytosisis a poor indicatorof acute osteomyelitis of the foot in diabetesmellitus. J Foot Ankle Surg 1996; 35: 280–3.34. Newman LG, Waller J, Palestro C, et al. Unsuspected osteomyelitisin diabetic foot ulcers: diagnosis and monitoringby leukocyte scanning with indium 111 oxyquinoline. JAMA1991; 266: 1246–51.35. Lavery LA, Armstrong DG, Quebedeaux TL, Walker SC.Puncture wounds: normal laboratory values in the face ofsevere infection in diabetics and non- diabetics. Am J Med1996; 101: 521–5.36. Kaleta JL, Fleischli JW, Reilly CH. The diagnosis of osteomyelitisin diabetes using erythrocyte sedimentation rate: apilot study. J Am Podiatr Assoc 2001; 91: 445–50.37. Sanders LJ, Frykberg RG. Charcot neuroarthropathy of thefoot. In: Levine and O’Neal’s The Diabetic Foot (6th ed).Bowker JH, Pfeifer MA, eds. Saint Louis: Mosby. 2001: 439–66.38. Perrennou D, Aboukrat P, Richard JL. Ostéoarthropathienerveuse du pied diabétique. In: Le pied diabétique. RichardJ-L, Vannereau D, eds. Paris: Editions MF. 2002: 183–207.